Fulvestrant | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fulvestrant
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Fulvestrant

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Fulvestrant

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 13 USDMF, 9 CEP/COS, 2 JDMF, 2 EU WC, 12 NDC API, 24 Listed Suppliers, $ API Reference Price

35 API Suppliers
13 USDMF
9 CEP/COS
2 JDMF
2 EU WC
12 NDC API
24 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

97 Drugs in Development

97 Drugs in Development

INTERMEDIATES

7 Intermediate Suppliers

7 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

62 FDF Dossiers, 19 FDA Orange Book, 13 Europe, 6 Canada, 4 Australia, 5 South Africa, 15 Listed Dossiers

62 FDF Dossiers
19 FDA Orange Book
13 Europe
6 Canada
4 Australia
5 South Africa
15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAMUSCULAR - 125MG/2.5ML (50MG/ML), SOLUTION;INTRAMUSCULAR - 250MG/5ML (50MG/ML)

SOLUTION;INTRAMUSCULAR - 125MG/2.5ML (50MG/ML)
SOLUTION;INTRAMUSCULAR - 250MG/5ML (50MG/ML)

RELATED EXCIPIENT COMPANIES

2 Nanjing Well Pharmaceutical, 1 Actylis, 2 Finar, 1 TopChem Pharmaceuticals

2 Nanjing Well Pharmaceutical
1 Actylis
2 Finar
1 TopChem Pharmaceuticals

EXCIPIENTS BY APPLICATIONS

3 Topical, 3 Parenteral, 1 Solubilizers

3 Topical
3 Parenteral
1 Solubilizers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 101 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
101 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 11 Finished Drug Prices, 10 Annual Reports

2 US Medicaid Prescriptions
11 Finished Drug Prices
10 Annual Reports

MARKET PLACE

6 APIs, 8 FDF Dossiers

6 APIs
8 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 1 Health Canada Patents

3 US Patents
1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 4 Others

2 EDQM
2 USP
4 Others

$ API Ref.Price (USD/KG) : 48,140 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1AstraZeneca Canada Inc.

filter Patent Reset all filters

1 All

01 12351004

filter Product Reset all filters

1 All

01 1Fulvestrant

filter Dosage Reset all filters

1 All

01 1Injectable Solution

filter Exp Date Reset all filters

1 All

01 12021-01-08

Minakem Fulvestrant

Product Main Page

01

AstraZeneca Canada Inc.

Fulvestrant

PharmScience R&D

Not Confirmed

AstraZeneca Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-01-08

Date Granted : 2003-02-18

Fulvestrant

Brand Name : FASLODEX

Patent Number : 2351004

Filing Date : 2001-01-08

Strength per Unit : 50 mg / mL

Dosage Form : Injectable Solution

Human Or VET : Human

Route of Administration : Intramuscular Injection

Patent Expiration Date : 2021-01-08

Date Granted : 2003-02-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!